publicationMetadata:
  pmid: "PMID:24040940"
  title: "Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors."
  queryType: "unknown"
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.95
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research â†’ antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    This publication involves molecular analysis of MPNST samples and cell lines, microarray analysis,
    qRT-PCR, immunofluorescence, and drug testing. Expected tools include cell lines, antibodies,
    computational analysis software, and potentially genetic reagents.
  overallAssessment: |
    This is a laboratory research study involving molecular analysis of MPNST samples and cell lines
    with extensive experimental methods including microarray analysis, qRT-PCR, immunofluorescence,
    and drug sensitivity testing. The publication should contain multiple research tools including
    cell lines, antibodies, and computational analysis software.

toolValidations: []

potentiallyMissedTools:
  - toolName: "NF96.2"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Cell line names with standard nomenclature not caught by initial mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "NF02.2"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Cell line names with standard nomenclature not caught by initial mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "NF94.3"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Cell line names with standard nomenclature not caught by initial mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "ABCC1 antibody (Abcam ab24102)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution, respectively"
    whyMissed: "Antibody with catalog number not caught by initial mining patterns"
    confidence: 0.98
    shouldBeAdded: Yes

  - toolName: "S100 antibody (Dako Z0311)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution, respectively"
    whyMissed: "Antibody with catalog number not caught by initial mining patterns"
    confidence: 0.98
    shouldBeAdded: Yes

  - toolName: "XenoBase"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "XenoBase-based analysis software, a molecular-guided therapy prediction methodology and reporting tool developed at the Van Andel Research Institute"
    whyMissed: "Specialized bioinformatics software not caught by initial mining patterns"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "Gene Targeted Therapy Map"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "gene list with significant expression deviation from the reference set are supplied directly to the Gene Targeted Therapy Map"
    whyMissed: "Specialized analysis tool not caught by initial mining patterns"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "PGSEA"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP"
    whyMissed: "Bioinformatics analysis method not caught by initial mining patterns"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "CMAP"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP"
    whyMissed: "Connectivity Map analysis tool not caught by initial mining patterns"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "Affymetrix U133 2.0 plus chip"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Affymetrix U133 2.0 plus chip arrays were performed at Clinical Research Laboratories"
    whyMissed: "Microarray platform not caught by initial mining patterns"
    confidence: 0.85
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "NF[0-9]{2,3}\\.[0-9]+"
    toolType: "cell_line"
    examples: ["NF96.2", "NF02.2", "NF94.3"]
    reasoning: "MPNST cell lines follow this specific naming convention with NF prefix and decimal notation"

  - patternType: "vendor_indicator"
    pattern: "\\(Abcam [a-z]{2}[0-9]+\\)|\\(Dako [A-Z][0-9]+\\)"
    toolType: "antibody"
    examples: ["(Abcam ab24102)", "(Dako Z0311)"]
    reasoning: "Antibodies with vendor and catalog number in parentheses are clear tool indicators"

  - patternType: "term"
    pattern: "XenoBase|Gene Targeted Therapy Map|PGSEA|CMAP"
    toolType: "computational_tool"
    examples: ["XenoBase", "PGSEA", "CMAP"]
    reasoning: "Specialized bioinformatics tools for molecular analysis and drug prediction"

  - patternType: "naming_convention"
    pattern: "Affymetrix U[0-9]+.*chip|GeneChip.*Array"
    toolType: "genetic_reagent"
    examples: ["Affymetrix U133 2.0 plus chip", "GeneChip Human Genome U133 Plus 2.0 Array"]
    reasoning: "Microarray platforms follow standard Affymetrix naming conventions"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 10
  newPatternsCount: 4
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - Initial mining failed to capture any tools despite this being a clear lab research publication
    - Multiple cell lines (NF96.2, NF02.2, NF94.3) with ATCC source were missed
    - Antibodies with clear vendor/catalog information were not detected
    - Specialized bioinformatics tools (XenoBase, PGSEA, CMAP) were not captured
    - Microarray platforms were not recognized as genetic reagents
  recommendations: |
    This publication contains numerous research tools that were completely missed by initial mining.
    All 10 potentially missed tools should be added as they represent genuine research tools used
    in the experimental methods. The suggested patterns would significantly improve detection of
    MPNST cell lines, antibodies with catalog numbers, and specialized bioinformatics tools.
    No observations were extracted since no tools were initially validated, but the Results section
    likely contains valuable phenotypic data about drug resistance and molecular characteristics.